Typicality: | 0.416 |
Saliency: | 0.337 |
in one study | 10 | location |
after 12 weeks | 6 | temporal |
in muscle | 5 | other |
subject → report → improvement | 37 |
subject → report → greater improvement | 3 |
negative | neutral | positive |
0.017 | 0.319 | 0.664 |
Raw frequency | 40 |
Normalized frequency | 0.337 |
Modifier score | 0.838 |
Perplexity | 251.856 |